Across TCGA pan-cancer cohorts, UMLILO RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of UMLILO’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where UMLILO RNA is repressed in tumor relative to normal tissue. In most cancer types UMLILO is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

KIRP are the cancer types where UMLILO tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UMLILO RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	All	−0.035	.021	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: UMLILO RNA expression & survival · all UMLILO data types